Federal grants to Stinginn, LLC
Stinginn, LLC in Miami, Florida received $4.3 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Cancer Treatment Research, with $3.4 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$4.3 million
- Awards5
- Awarded in FY 2025$0
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 3 | $1.6 million |
| FY 2023 | 3 | $1.7 million |
| FY 2024 | 1 | $999,969 |
| FY 2025 | 0 | $0 |
Programs that fund Stinginn, LLC
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 3 | $3.4 million |
| Allergy and Infectious Diseases Research | 2 | $888,155 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $4.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Sting activators as therapy for cancer - project summary the immuno-oncology (IO) arena affords a new and exciting approach to stimulate the body’s own immune system to fight cancer. The generation of anti-cancer t cells is predominantly triggered by phagocytosed cancer cells stimulating innate immu | Cancer Treatment Research | September 22, 2022 | $2.0 million |
| Human t cell lymphotropic virus vaccine development - project summary for this proposal we intend to evaluate the safety and efficacy of a novel immunotherapeutic vaccine to prevent and possibly treat human t cell leukemia virus TYPE-1 (HTLV-1) associated diseases. HTLV-1 is a human retrovirus that | Cancer Treatment Research | August 15, 2024 | $999,969 |
| Human t cell lymphotropic virus vaccine development - project summary: for this proposal we intend to develop a novel vaccine to prevent and possibly treat human t cell leukemia virus TYPE-1 (HTLV-1) associated diseases. HTLV-1 is a human retrovirus that is the causative agent of a malignant CD4+ t | Allergy and Infectious Diseases Research | January 24, 2022 | $588,155 |
| Human specific sting agonists for the treatment of cancer - project summary cellular innate immune sensors, such as sting (stimulator of interferon genes), have evolved to detect microbial infection of the cell (1-3). Sting controls the potent cytosolic dna-stimulated innate immune pathways and is a | Cancer Treatment Research | July 10, 2023 | $399,812 |
| Anti-inflammatory activity of a systemic sting inhibitory non-nucleotide - project summary cellular innate immune sensors, such as sting (stimulator of interferon genes), have evolved to detect microbial infection of the cell. Sting controls the potent cytosolic dna-stimulated innate immune pathways | Allergy and Infectious Diseases Research | December 17, 2021 | $300,000 |
Questions people ask
How much federal grant money does Stinginn, LLC get?
$4.3 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Stinginn, LLC the most?
The Department of Health and Human Services, with $4.3 million in 5 awards.
What is Stinginn, LLC's largest federal grant?
$2.0 million under Cancer Treatment Research, with its first action in the period on September 22, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Stinginn, LLC?
Its largest are Cancer Treatment Research and Allergy and Infectious Diseases Research.
Other grant recipients in Miami
- County of Miami-Dade
- University of Miami
- Florida International University
- Miami-Dade County
- County of Miami-Dade
- Dade County Aviation
- Miami Dade College
- Miami-Dade County
Largest federal grant recipients in Florida · Federal grants in Florida